Medication Error Rate Benchmark
Contents |
for benchmarking. Yet, we must question the wisdom of applying the benchmarking concept to the medication medication error rate calculation use process when the focus is on error rates. The true rate of medication errors in hospitals incidence of medication errors varies, depending heavily on the rigor with which the events are identified medication error statistics 2015 and reported.. Certainly, the confusion surrounding the term "benchmarking"perpetuates the myth that one can gauge the quality and safety of the medication use process simply by medication error definition comparing error rates, both within an organization and externally. Benchmarking is an ongoing process that determines how other organizations have achieved the best performance and suggests ways for adapting the best practices that result in this exceptional performance. Although measurement is one of its components, effective benchmarking is a dual process that
Medication Errors In Hospitals Statistics 2014
requires two products: benchmarks and enablers.1 Benchmarks are measures of comparative performance that answer the question: "What is your level of performance?" Alone, this information has little use in improving performance. Benchmarking must also provide a systematic method of understanding the underlying processes that determine organizational performance. To that end, enablers must be identified. Enablers are the specific practices that lead to exemplary performance and answer the question: "How do you do it?" Overlooking either one of these components in the benchmarking process renders it useless, even dangerous! Currently, there is no consistent process among healthcare organizations for detecting and reporting errors. Since many medication errors cause no harm to patients, they remain undetected or unreported. Still, organizations frequently depend on spontaneous voluntary error reports alone to determine a medication error rate. The inherent variability of determining an error rate in this way invalidates the measurement, or benchmark. A high error rate may suggest either uns
Me Forgot Password? Login or Sign up for a Free Account My Topics of Interest My CME My Profile Sign Out Home Topics Issues WebM&M Cases Perspectives Primers Submit Case CME / CEU Training Catalog Info Glossary About PSNet Help
Medication Errors Statistics
& FAQ Contact PSNet Email Updates Editorial Team Technical Expert/Advisory Panel Terms & Conditions medication errors in nursing / Copyright PSNet Privacy Policy External Link Disclaimer Patient Safety Primer Last Updated: March 2015 Medication Errors Topics Resource Type Patient what percentage of medication errors occur in neonatal intensive care units? Safety Primers Safety Target Medication Errors/Preventable Adverse Drug Events Look-Alike, Sound-Alike Drugs More Share Facebook Twitter Linkedin Email Print Background and definitions Prescription medication use is widespread, complex, and increasingly risky. Clinicians have http://www.ismp.org/newsletters/acutecare/articles/19980909.asp access to an armamentarium of more than 10,000 prescription medications, and nearly one-third of adults in the United States take 5 or more medications. Advances in clinical therapeutics have undoubtedly resulted in major improvements in health for patients with many diseases, but these benefits have also been accompanied by increased risks. An adverse drug event (ADE) is defined as harm experienced by a patient as a result of exposure to https://psnet.ahrq.gov/primers/primer/23/medication-errors a medication, and ADEs account for nearly 700,000 emergency department visits and 100,000 hospitalizations each year. ADEs affect nearly 5% of hospitalized patients, making them one of the most common types of inpatient errors; ambulatory patients may experience ADEs at even higher rates. Transitions in care are also a well-documented source of preventable harm related to medications. As with the more general term adverse event, the occurrence of an ADE does not necessarily indicate an error or poor quality care. A medication error refers to an error (of commission or omission) at any step along the pathway that begins when a clinician prescribes a medication and ends when the patient actually receives the medication. Preventable adverse drug events result from a medication error that reaches the patient and causes any degree of harm. It is generally estimated that about half of ADEs are preventable. Medication errors that do not cause any harm—either because they are intercepted before reaching the patient, or by luck—are often called potential ADEs. An ameliorable ADE is one in which the patient experienced harm from a medication that, while not completely preventable, could have been mitigated. Finally, a certain percentage of patients will experience ADEs even when medications are prescribed and administered appropriately; the
Health https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310841/ Search databasePMCAll DatabasesAssemblyBioProjectBioSampleBioSystemsBooksClinVarCloneConserved DomainsdbGaPdbVarESTGeneGenomeGEO DataSetsGEO ProfilesGSSGTRHomoloGeneMedGenMeSHNCBI http://patientsafetyauthority.org/ADVISORIES/AdvisoryLibrary/2004/dec1(4)/Pages/19.aspx Web SiteNLM CatalogNucleotideOMIMPMCPopSetProbeProteinProtein ClustersPubChem BioAssayPubChem CompoundPubChem SubstancePubMedPubMed HealthSNPSparcleSRAStructureTaxonomyToolKitToolKitAllToolKitBookToolKitBookghUniGeneSearch termSearch Advanced Journal list Help Journal ListAnn Intensive Carev.2; 2012PMC3310841 Ann Intensive Care. 2012; 2: 2. Published online 2012 medication error Feb 16. doi: 10.1186/2110-5820-2-2PMCID: PMC3310841Overview of medical errors and adverse eventsMaité Garrouste-Orgeas,1,2 François Philippart,1,3,4 Cédric Bruel,1 Adeline Max,1 Nicolas Lau,1 and B Misset1,31Réanimation médico-chirurgicale, Groupe Hospitalier Paris Saint Joseph, Paris, France2Université Joseph Fourier, medication errors in Unité INSERM, Epidémiologie des cancers et des maladies sévères, Institut Albert Bonniot, La Tronche, France3Medicine Faculty, Université Paris Descartes, Paris, France4Infection and Epidemiology department Pasteur Institut, Paris, FranceCorresponding author.Maité Garrouste-Orgeas: rf.jsph@etsuorragm; François Philippart: rf.jsph@trappilihpf; Cédric Bruel: rf.jsph@leurbc; Adeline Max: rf.jsph@xama; Nicolas Lau: rf.jsph@ualn; B Misset: rf.jsph@tessimb Author information ► Article notes ► Copyright and License information ►Received 2011 Sep 30; Accepted 2012 Feb 16.Copyright ©2012 Garrouste-Orgeas et al; licensee Springer.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, pro
Know Governance Job Openings Login to PA-PSRS About PA-PSRS Data Interface Facility Reporting Information Login to PassKey About PassKey Advisory Library Patient and Consumer Tips Press Releases Healthcare-Associated Infections Brochures Related Organization Links The Authority in the News Driving Change Patient Safety Tools Calendar Public Meetings ADDRESS: Patient Safety Authority 333 Market Street Lobby Level Harrisburg, PA 17120 Phone: 717-346-0469 Fax: 717-346-1090 SearchAdvanced Search Understanding the Benchmarking Process PA PSRS Patient Saf Advis 2004 Dec;1(4):19. _______________This article is excerpted from the book Medication Errors by Michael Cohen, RPh, MS, ScD. Dr. Cohen is President of the Institute for Safe Medication Practices (ISMP) and serves as an expert advisor to PA-PSRS in the area of medication safety._______________Benchmarking is an ongoing process that determines how other organizations have achieved optimal performance. Through the process of benchmarking, ways are suggested for adapting the best practices that result in exception performance. Although measurement is one of its components, effective benchmarking is a dual process that requires two products: performance measurement and enablers.Benchmarks are measures of comparative performance that answer the question: What is your level of performance? By itself, this information has little use in improving performance. To be effective, benchmarking must also provide a systematic method of understanding the underlying process that determines an organization’s performance. To that end, enablers must be identified. Enablers are the specific practices that lead to exemplary performance; they answer the question: How do you do it? Overlooking either one of these components in the benchmarking process renders it useless, even dangerous.Although medication error rates, for example, may seem ideal for benchmarking, we must question the wisdom of applying the benchmarking concept to the medication use process when the focus is on error rates. Certainly, the confusion surrounding the term “benchmarking” perpetuates the myth that one can gauge the quality and safety of the medication use process simply by comparing error rates, both with